AMYPAD Diagnostic and Patient Management Study: Rationale and design-Reference-Cited by-同舟云学术

AMYPAD Diagnostic and Patient Management Study: Rationale and design

Published:2018-10-16 Issue:3 Volume:15 Page:388-399
ISSN:1552-5260
Container-title:Alzheimer's & Dementia
language:en
Short-container-title:Alzheimer's & Dementia

Author:

Frisoni Giovanni B.¹²³,Barkhof Frederik⁴⁵,Altomare Daniele³⁶,Berkhof Johannes⁷,Boccardi Marina¹³,Canzoneri Elisa¹,Collij Lyduine⁴,Drzezga Alexander⁸,Farrar Gill⁹,Garibotto Valentina¹⁰¹¹,Gismondi Rossella¹²,Gispert Juan‐Domingo¹³¹⁴,Jessen Frank¹⁵¹⁶,Kivipelto Miia¹⁷¹⁸¹⁹²⁰,Lopes Alves Isadora⁴,Molinuevo José Luis¹³,Nordberg Agneta¹⁷¹⁸,Payoux Pierre²¹²²,Ritchie Craig²³,Savicheva Irina²⁴,Scheltens Philip²⁵,Schmidt Mark E.²⁶,Schott Jonathan M.²⁷,Stephens Andrew²⁸,Berckel Bart⁴,Vellas Bruno²⁹³⁰,Walker Zuzana³¹³²,Raffa Nicola³³

Affiliation:

1. Laboratory of Neuroimaging of Aging (LANVIE)University of GenevaGenevaSwitzerland

2. Memory ClinicUniversity Hospital of GenevaGenevaSwitzerland

3. Laboratory of Alzheimer's Neuroimaging and Epidemiology (LANE)Saint John of God Clinical Research CentreBresciaItaly

4. Department of Radiology and Nuclear MedicineAmsterdam NeuroscienceVU University Medical CenterAmsterdamthe Netherlands

5. Institutes of Neurology and Healthcare EngineeringUCLLondonUnited Kingdom

6. Department of Molecular and Translational MedicineUniversity of BresciaBresciaItaly

7. Department of Epidemiology and BiostatisticsVU University Medical CenterAmsterdamthe Netherlands

8. Department of Nuclear MedicineUniversity Hospital of CologneUniversity of Cologne and German Center for Neurodegenerative Diseases (DZNE)Germany

9. Life SciencesGE HealthcareAmershamBuckinghamshireUnited Kingdom

10. Division of Nuclear Medicine and Molecular ImagingDepartment of Medical ImagingUniversity Hospitals of GenevaGenevaSwitzerland

11. NIMTlabFaculty of MedicineGeneva UniversityGenevaSwitzerland

12. Piramal ImagingMedical AffairsBerlinGermany

13. Barcelonaβeta Brain Research CenterPasqual Maragall FoundationBarcelonaSpain

14. Centro de Investigación Biomédica en Red de BioingenieríaBiomateriales y Nanomedicina (CIBER‐BBN)MadridSpain

15. Department of Psychiatry and PsychotherapyUniversity of CologneCologneGermany

16. German Center for Neurodegenerative Diseases (DZNE)BonnGermany

17. Department of NeurobiologyCare Sciences and SocietyCenter for Alzheimer ResearchDivision of Clinical GeriatricsKarolinska InstitutetStockholmSweden

18. Aging ThemeKarolinska University Hospital StockholmSweden

19. University of Eastern FinlandFinland

20. School of Public HealthImperial CollegeLondonUnited Kingdom

21. Nuclear Medicine DepartmentUniversity Hospital of Toulouse (CHU‐Toulouse)ToulouseFrance

22. ToNICToulouse NeuroImaging CenterUniversité de ToulouseInsermUPSToulouseFrance

23. Centre for Clinical Brain SciencesDepartment of PsychiatryUniversity of EdinburghEdinburghUnited Kingdom

24. Nuclear Medicine IRAMedical Radiation Physics and Nuclear Medicine ImagingKarolinska University HospitalSweden

25. Alzheimer Center and Department of NeurologyAmsterdam NeuroscienceVU University Medical CenterAmsterdamthe Netherlands

26. Experimental MedicineJanssen Pharmaceutica NVBeerseBelgium

27. Institute of NeurologyUniversity College LondonLondonUnited Kingdom

28. Piramal ImagingClinical Research and DevelopmentBerlinGermany

29. Gerontopole of ToulouseUniversity Hospital of Toulouse (CHU‐Toulouse)ToulouseFrance

30. UMR INSERM 1027University of Toulouse IIIToulouseFrance

31. Division of PsychiatryUniversity College LondonLondonUnited Kingdom

32. Essex Partnership University NHS Foundation TrustUnited Kingdom

33. Piramal ImagingMarket Access and HEORBerlinGermany

Funder

AbbVie

Acadia University

Biogen

Novartis

GE Healthcare

H. Lundbeck A/S

Merck

Avid Radiopharmaceuticals

General Electric

EFPIA

Acadia

Altoida

Amoneta

Araclon

Janssen

Piramal

Avid-Lilly

AMYPAD

EuroPOND

UK MS Society

Dutch MS Society

PICTURE

NIHR

ECTRIMS

Siemens Healthcare

Lilly

German Research Foundation

Eli Lilly

Axovant

Boehringer

Lundbeck

Takeda

Pfizer

Eisai

Actinogen

Kyowa Pharmaceutical

Avid Radiopharmaceuticals, Piramal imaging

ZON-MW

Publisher

Wiley

Subject

Psychiatry and Mental health,Cellular and Molecular Neuroscience,Geriatrics and Gerontology,Neurology (clinical),Developmental Neuroscience,Health Policy,Epidemiology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1016/j.jalz.2018.09.003

Reference49 articles.

1. Cerebral PET with florbetapir compared with neuropathology at autopsy for detection of neuritic amyloid-β plaques: a prospective cohort study

2. Florbetaben PET imaging to detect amyloid beta plaques in Alzheimer's disease: Phase 3 study

3. Performance of [ 18 F]flutemetamol amyloid imaging against the neuritic plaque component of CERAD and the current (2012) NIA‐AA recommendations for the neuropathologic diagnosis of Alzheimer's disease;Salloway S;Alzheimer's Dement Diagnosis, Assess Dis Monit,2017

4. Florbetapir F18 (Amyvid) ‐ European Medicines Agency (EMA). Available at:http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/002422/human_med_001611.jsp&mid=WC0b01ac058001d124. Accessed February 23 2018.

5. Florbetapir F18 (Amyvid) ‐ Food and Drug Administration (FDA) Available at:https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/202008s000lbl.pdfAccessed February 23 2018.

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Stress testing the Centiloid: Precision and variability of PET quantification of amyloid pathology;Alzheimer's & Dementia;2024-07-04

2. Computerized decision support is an effective approach to select memory clinic patients for amyloid-PET;PLOS ONE;2024-05-20

3. Quantitative Brain Amyloid PET;Journal of Nuclear Medicine;2024-03-21

4. PET Imaging in Dementia: Mini-Review and Canadian Perspective for Clinical Use;Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques;2024-03-04

5. Emerging Role of Extracellular Vesicles in Intercellular Communication in the Brain: Implications for Neurodegenerative Diseases and Therapeutics;Cell Biochemistry and Biophysics;2024-02-01